Agastiya Biotech

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Agastiya Biotech merges advanced, Eastern botanical knowledge with rigorous Western R&D and AI driven analysis to deliver breakthrough innovative pharmaceuticals that are engineered to be the best in class novel small molecules for treatment of disease.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2019
Main Therapeutic Focus:
Lead Product in Development:
Mutant KRAS Inhibitor - ABREV001
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3
Speaker
photo
COO
Agastiya Biotech